Related Experiment Video
Updated: Aug 19, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
Published on: October 29, 2014
Pathophysiologic effects of a toxic peptide from Microcystis aeruginosa
Abstract:
Toxin-LR, a hexapeptide produced by Microcystis aeruginosa, causes marked hepatic vascular congestion, thrombocytopenia, microscopic pulmonary thrombi and death in 50-70 min when injected into mice. Although it is considered an hepatotoxin, we report that sublethal hepatocellular damage produced by CCl4 given 24 hr prior to toxin-LR administration prevents the acute deaths. However, CCl4-treated mice surviving toxin-LR acute effects often died during the subsequent three days. Pretreatment of mice with the microsomal enzyme inhibitors SKF 525A or cobaltous chloride did not alter the acute lethality of toxin-LR, but pharmacologic doses of hydrocortisone prevented both the acute and delayed deaths. X irradiation-induced thrombocytopenia or thrombocytopenia and leukopenia did not significantly affect the toxin's lethality. In vitro platelet aggregation or lysis did not occur during incubation with toxin-LR, nor was a humoral aggregating factor detected in plasma from toxin-injected mice.
Insights
Hepatocellular damage from CCl4 protects mice from acute Toxin-LR death. However, hydrocortisone prevents both acute and delayed deaths, suggesting a role beyond direct liver toxicity for this cyanotoxin.
Area of Science:
- Toxicology
- Pharmacology
- Hepatology
Background:
- Microcystis aeruginosa produces Toxin-LR, a hexapeptide known for acute toxicity.
- Toxin-LR causes hepatic vascular congestion, thrombocytopenia, and pulmonary thrombi, leading to rapid death in mice.
- Its classification as solely an hepatotoxin is questioned by observed protective mechanisms.
Purpose of the Study:
- To investigate the protective effects of prior hepatocellular damage on Toxin-LR lethality.
- To explore the role of microsomal enzymes and hydrocortisone in Toxin-LR toxicity.
- To determine if Toxin-LR directly affects platelet aggregation or induces a humoral factor.
Main Methods:
- Mice were pretreated with carbon tetrachloride (CCl4) to induce hepatocellular damage before Toxin-LR administration.
- Mice were pretreated with microsomal enzyme inhibitors (SKF 525A, cobaltous chloride) and hydrocortisone.
- Effects of X-irradiation-induced thrombocytopenia on lethality were assessed.
- In vitro platelet aggregation and detection of humoral factors in plasma were performed.
Main Results:
- Sublethal CCl4 pretreatment prevented acute Toxin-LR deaths, but delayed mortality increased.
- Microsomal enzyme inhibitors did not alter acute lethality.
- Pharmacologic doses of hydrocortisone prevented both acute and delayed deaths.
- Thrombocytopenia or leukopenia did not significantly affect Toxin-LR lethality.
- No in vitro platelet aggregation or lysis was observed; no humoral aggregating factor was detected.
Conclusions:
- Hepatocellular damage can mitigate acute Toxin-LR lethality, indicating a complex toxic mechanism.
- Hydrocortisone demonstrates significant protective effects against both acute and delayed Toxin-LR toxicity.
- Toxin-LR's lethality is not solely dependent on direct platelet effects or induced humoral factors.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Bioactivation and Tissue Toxicity
Bacterial Toxins
Diphtheria
Cytotoxic Edema: Pathophysiology
Hepatic Encephalopathy

